In addition to the numerous hearings and markups on the opioid crisis discussed in a separate post, Congressional committees are examining the following health policy topics:

• The Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing to review HHS Office of Inspector General and Government Accountability Office oversight reports regarding the 340B drug pricing program.
• The House Ways and Means Health Subcommittee held a hearing on Medicare Advantage plan quality.
• The Senate Aging Committee held a hearing on insulin treatment costs.

In addition, the Senate HELP committee is holding a May 22, 2018 hearing on the health care workforce.